2021 Update on Diffuse large B cell lymphoma: A review of current data and potential applications on risk stratification and management von Susanibar‐Adaniya, Sandra, Barta, Stefan K.

Volltext

Is it prime time for T-cell lymphoma? von Barta, Stefan K.

Volltext

Diffuse large B‐cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment von Liu, Yang, Barta, Stefan Klaus

Volltext

Clinical Pharmacokinetics and Pharmacodynamics of Bortezomib von Tan, Carlyn Rose C., Abdul-Majeed, Saif, Cael, Brittany, Barta, Stefan K.

Volltext

2024 Update: Advances in the risk stratification and management of large B‐cell lymphoma von Tavakkoli, Montreh, Barta, Stefan K.

Volltext

Brentuximab vedotin in the treatment of CD30+ PTCL von Barta, Stefan K., Gong, Jerald Z., Porcu, Pierluigi

Volltext

A novel model of controlling PD-L1 expression in ALK+ anaplastic large cell lymphoma revealed by CRISPR screening von Zhang, Jing-Ping, Song, Zhihui, Wang, Hong-Bo, Lang, Lang, Yang, Yuan-Zhong, Xiao, Wenming, Webster, Daniel E., Wei, Wei, Barta, Stefan K., Kadin, Marshall E., Staudt, Louis M., Nakagawa, Masao, Yang, Yibin

Volltext

T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy von Ghilardi, Guido, Fraietta, Joseph A., Gerson, James N., Van Deerlin, Vivianna M., Morrissette, Jennifer J. D., Caponetti, Gabriel C., Paruzzo, Luca, Harris, Jaryse C., Chong, Elise A., Susanibar Adaniya, Sandra P., Svoboda, Jakub, Nasta, Sunita D., Ugwuanyi, Ositadimma H., Landsburg, Daniel J., Fardella, Eugenio, Waxman, Adam J., Chong, Emeline R., Patel, Vrutti, Pajarillo, Raymone, Kulikovskaya, Irina, Lieberman, David B., Cohen, Adam D., Levine, Bruce L., Stadtmauer, Edward A., Frey, Noelle V., Vogl, Dan T., Hexner, Elizabeth O., Barta, Stefan K., Porter, David L., Garfall, Alfred L., Schuster, Stephen J., June, Carl H., Ruella, Marco

Volltext

A20 and RBX1 Regulate Brentuximab Vedotin Sensitivity in Hodgkin Lymphoma Models von Wei, Wei, Lin, Yuquan, Song, Zhihui, Xiao, Wenming, Chen, Liqi, Yin, Jiejing, Zhou, Yan, Barta, Stefan K, Petrus, Michael, Waldmann, Thomas A, Yang, Yibin

Volltext

SOHO State of the Art Updates and Next Questions | Challenging Cases in Rare T-Cell Lymphomas von Bhansali, Rahul S., Barta, Stefan K.

Volltext

Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients von Barta, Stefan K., Xue, Xiaonan, Wang, Dan, Tamari, Roni, Lee, Jeannette Y., Mounier, Nicolas, Kaplan, Lawrence D., Ribera, Josep-Maria, Spina, Michele, Tirelli, Umberto, Weiss, Rudolf, Galicier, Lionel, Boue, Francois, Wilson, Wyndham H., Wyen, Christoph, Oriol, Albert, Navarro, José-Tomás, Dunleavy, Kieron, Little, Richard F., Ratner, Lee, Garcia, Olga, Morgades, Mireia, Remick, Scot C., Noy, Ariela, Sparano, Joseph A.

Volltext

Identification of a clinicopathologic prognostic index for newly diagnosed large B cell lymphoma patients treated with R-CHOP von Ni, Vincent, Nasta, Sunita D, Barta, Stefan K, Schuster, Stephen J, Chong, Elise A, Svoboda, Jakub, Morrissette, Jennifer J D, Barlev, Ashley, Bagg, Adam, Priore, Salvatore F, Landsburg, Daniel J

Volltext

Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs von Matasar, Matthew J., Luminari, Stefano, Barr, Paul M., Barta, Stefan K., Danilov, Alexey V., Hill, Brian T., Phillips, Tycel J., Jerkeman, Mats, Magagnoli, Massimo, Nastoupil, Loretta J., Persky, Daniel O., Okosun, Jessica

Volltext

Targeted Therapies in the Treatment of Mantle Cell Lymphoma von Thomas, Colin J, Carvajal, Veronica, Barta, Stefan K

Volltext

Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell Lymphoma von Wright, Christopher M., LaRiviere, Michael J., Baron, Jonathan A., Uche, Chibueze, Xiao, Ying, Arscott, W. Tristram, Anstadt, Emily J., Barsky, Andrew R., Miller, David, LaRose, Meredith I., Landsburg, Daniel J., Svoboda, Jakub, Nasta, Sunita D., Gerson, James N., Barta, Stefan K., Chong, Elise A., Schuster, Stephen J., Paydar, Ima, Maity, Amit, Plastaras, John P.

Volltext

Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas von Svoboda, Jakub, Bair, Steven M, Landsburg, Daniel J, Dwivedy Nasta, Sunita, Nagle, Sarah J, Barta, Stefan K, Khan, Nadia, Filicko-O'Hara, Joanne, Gaballa, Sameh, Strelec, Lauren, Chong, Elise, Mitnick, Sheryl, Waite, Terease S, King, Cara, Ballard, Hatcher, Youngman, Matthew, Gerson, James, Plastaras, John P, Maity, Amit, Bogusz, Agata M, Hung, Stacy S, Nakamura, Hisae, Nejati, Reza, Steidl, Christian, Lim, Megan, Ruella, Marco, Schuster, Stephen J

Volltext

To be or not to be HIV+, that is no longer the question von Barta, Stefan K.

Volltext

Central Nervous System Progression/Relapse in Mature T- and NK-Cell Lymphomas von Bhansali, Rahul S, Barta, Stefan K

Volltext

Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission von Landsburg, Daniel J, Falkiewicz, Marissa K, Maly, Joseph, Blum, Kristie A, Howlett, Christina, Feldman, Tatyana, Mato, Anthony R, Hill, Brian T, Li, Shaoying, Medeiros, L Jeffrey, Torka, Pallawi, Hernandez-Ilizaliturri, Francisco, Reddy, Nishitha M, Singavi, Arun, Fenske, Timothy S, Chavez, Julio C, Kaplan, Jason B, Behdad, Amir, Petrich, Adam M, Bast, Martin A, Vose, Julie M, Olszewski, Adam J, Costa, Cristiana, Lansigan, Frederick, Gerson, James N, Barta, Stefan K, Calzada, Oscar, Cohen, Jonathon B, Lue, Jennifer K, Amengual, Jennifer E, Rivera, Xavier, Persky, Daniel O, Peace, David J, Nathan, Sunita, Cassaday, Ryan D

Volltext

EXABS-111-NHL Challenging Cases in Rare T-Cell Lymphomas von Bhansali, Rahul S, Barta, Stefan K

Volltext